21st International AIDS Conference (AIDS 2016)


NIH's Dr. Dieffenbach Shares Final Update From AIDS 2016

July 20, 2016

In his third and final update from the International AIDS Conference (AIDS 2016) in Durban, South Africa, NIH's Dr. Carl Dieffenbach discussed highlights of ongoing HIV cure research presented at the conference. Dr. Dieffenbach, the Director of the Division of AIDS at NIH's National Institute of Allergy and Infectious Diseases (NIAID), spoke with his colleague Anne Rancourt via Facebook Live.

Their discussion focused on the status of ongoing HIV cure research and some of the discussions around it at the conference. They also responded to several questions from viewers of their three Facebook Live events from the conference. They concluded with thoughts on the effects of stigma.

In case you missed it, you can view the recorded version of their Facebook Live interview here.

Or watch below.

Dr. Dieffenbach mentioned Dr. Tony Fauci's TED Talk. Watch that here.

Related Stories

NIH's Dr. Dieffenbach Shares Updates on HIV Vaccine Research From Second Day of AIDS 2016
NIH's Dr. Dieffenbach Shares Perspectives From First Day of AIDS 2016
CDC's Drs. Hader and McCray Discuss Developments From AIDS 2016

This article was provided by It is a part of the publication The 21st International AIDS Conference (AIDS 2016).

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.